Skip to main content
. 2018 Nov 27;3(1):74–83. doi: 10.1002/hep4.1285

Table 1.

Characteristics of U.S. Female Adults by NAFLD Status, NHANES (1988‐2014)

Characteristics No NAFLD (n = 9,748) NAFLD (n = 3,811) ALL (n = 13,559)
n Weighted % ± SEM n Weighted % ± SEM* n Weighted % ± SEM
Age, years 44.35 ± 0.32 53.16 ± 0.40 46.38 ± 0.29
Age, %
20‐44 5,482 57.62 ± 0.86 1,223 32.59 ± 1.18 6,705 51.86 ± 0.71
45‐64 2,466 27.98 ± 0.68 1,406 40.55 ± 1.25 3,872 30.87 ± 0.55
≥65 1,800 14.40 ± 0.63 1,182 26.86 ± 1.09 2,982 17.27 ± 0.63
RACE, %
non‐Hispanic white 4,550 72.77 ± 1.24 1,508 68.87 ± 1.52 6,058 71.87 ± 1.20
non‐Hispanic black 2,562 12.24 ± 0.70 618 9.02 ± 0.67 3,180 11.50 ± 0.65
Hispanic 1,967 7.29 ± 0.50 1,503 16.28 ± 1.16 3,470 9.36 ± 0.60
Other 669 7.70 ± 0.59 182 5.83 ± 0.77 851 7.27 ± 0.52
Income (PIR), %
Low (PIR <1.3) 2,722 19.76 ± 0.92 1,346 26.96 ± 1.09 4,068 21.41 ± 0.82
Middle (1.3<PIR<3.5) 3,558 38.79 ± 0.84 1,381 42.02 ± 1.38 4,939 39.53 ± 0.76
High (PIR >3.5) 2,677 41.45 ± 1.07 723 31.01 ± 1.59 3,400 39.07 ± 1.04
Current smoker, % 1,787 23.00 ± 0.68 543 18.88 ± 1.02 2,330 22.08 ± 0.64
Metabolic components, %
Obesity 2,083 18.13 ± 0.55 2,583 70.54 ± 1.08 4,666 30.15 ± 0.68
Type 2 diabetes mellitus 475 3.16 ± 0.19 1,135 26.24 ± 0.85 1,610 8.45 ± 0.31
Hypertension 2,598 21.85 ± 0.63 2,081 53.79 ± 1.06 4,679 29.20 ± 0.61
Hyperlipidemia 6,548 64.85 ± 0.78 3,320 88.49 ± 0.67 9,868 70.29 ± 0.64
Metabolic syndrome 848 6.32 ± 0.31 1,752 45.20 ± 1.03 2,600 15.27 ± 0.44
Comorbidities, %
Cancer 721 8.31 ± 0.36 380 12.26 ± 0.72 1,101 9.22 ± 0.33
COPD 654 7.44 ± 0.44 367 11.90 ± 0.86 1,021 8.46 ± 0.39
CVD 490 4.04 ± 0.25 457 10.30 ± 0.61 947 5.48 ± 0.27
ASCVD ≥7.5% 2,076 16.89 ± 0.58 1,565 37.16 ± 1.21 3,641 21.51 ± 0.60
CVD or ASCVD ≥7.5% 2,237 17.99 ± 0.60 1,687 38.66 ± 1.22 3,924 22.75 ± 0.61
*

Significantly different from no NAFLD.

Expressed as weighted mean ± SEM.